David Schechner has joined JMP Securities as a managing director in its healthcare investment banking group. Schechner was previously with Robert W. Baird & Co, where he led biotechnology, pharmaceutical, and pharmaceutical services.
SAN FRANCISCO–(BUSINESS WIRE)–JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that David Schechner has joined JMP Securities as a managing director in its healthcare investment banking group. Based in the firm’s Boston office, Mr. Schechner will focus on the biotechnology, pharmaceutical and specialty pharmaceutical industries.
“David is an excellent addition to our healthcare franchise,” said Carter Mack, president of JMP Group. “With more than 25 years of Wall Street experience, he has built and managed several respected life sciences investment banking practices. He understands not only the capital markets dynamics specific to life sciences companies but also the M&A environment for them. We are confident that David will be a key contributor to JMP Securities’ continuing success in the healthcare sector.”
Mr. Schechner joins JMP Securities from Robert W. Baird & Co., where he led biotechnology, pharmaceutical, and pharmaceutical services investment banking since 2012. He was previously head of the pharmaceuticals investment banking group at Canaccord Genuity, after founding and leading the biotechnology investment banking group at Needham & Company. Mr. Schechner also held senior investment banking roles at Goldman Sachs and Bear Stearns, focusing on healthcare and technology. He holds an MBA from Harvard Business School and a BA from Cornell University.
About JMP Group
JMP Group LLC is a diversified capital markets firm that provides investment banking, equity research, and sales and trading services to corporate and institutional clients as well as alternative asset management products and services to institutional and high-net-worth investors. JMP Group conducts its investment banking and research, sales and trading activities through JMP Securities; its hedge fund, venture and private capital, and credit management activities through Harvest Capital Strategies and JMP Asset Management; and the management of Harvest Capital Credit Corporation (NASDAQ: HCAP), a business development company, through HCAP Advisors. For more information, visit www.jmpg.com.